EditorialOpen Access
The Agentic Era: Why Biopharma Must Embrace Artificial Intelligence That Acts, Not Just Informs
Cureus · 03.05.2025
DOI: 10.7759/cureus.83390 ↗Kurz gefasst
Editorial in der Zeitschrift Cureus, erschienen am 03.05.2025. Verfasst von Shaheen E Lakhan. Beteiligte Einrichtung: Bioscience, Global Neuroscience Initiative Foundation, Miami, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
agentic aiartificial intelligenceautonomous systemsclinical trialsdrug developmentregulatory transformation
Autor:innen und Institutionen
- Bioscience, Global Neuroscience Initiative Foundation, Miami, USA.
- Neurology, A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, USA.
- Neurology, Morehouse School of Medicine, Atlanta, USA.
- Neurology, Western University of Health Sciences, Pomona, USA.
Zitieren
APA
Lakhan, S. E. (2025). The Agentic Era: Why Biopharma Must Embrace Artificial Intelligence That Acts, Not Just Informs. Cureus. https://doi.org/10.7759/cureus.83390
Vancouver
Lakhan SE. The Agentic Era: Why Biopharma Must Embrace Artificial Intelligence That Acts, Not Just Informs. Cureus. 2025. doi:10.7759/cureus.83390
BibTeX
@article{Lakhan2025,
author = {Lakhan, Shaheen E},
title = {The Agentic Era: Why Biopharma Must Embrace Artificial Intelligence That Acts, Not Just Informs},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.83390}
}
EUVIMED